Author | Sarah L. Anzick, PhD

Articles

Role of Genomics in Identifying New Targets for Cancer Therapy

May 01, 2002

The detailed map of the human genome can potentially transform future cancer therapy by merging genomics with pharmacology, thereby identifying which patients will benefit from specific therapeutic agents. Single-nucleotide polymorphisms (SNPs) provide a valuable tool for this pharmacogenetic approach to cancer therapy.